Endocrinology, Vol 134, 2498-2504, Copyright © 1994 by Endocrine Society

ARTICLES

Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex

E Chin, J Zhou, J Dai, RC Baxter and CA Bondy
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Insulin-like growth factors (IGFs) are present in the circulation, largely as part of a high mol wt complex including IGF-binding protein- 3 (IGFBP-3) and an acid-labile subunit (ALS). This study used in situ hybridization to investigate the cellular sites of synthesis of these factors in the rat and to evaluate changes in transcript levels during development and after hypophysectomy and GH treatment. IGFBP-3 transcripts are considerably more abundant and widely expressed than ALS at birth, but both are present in liver and kidney. Hepatic IGFBP-3 gene expression increases slightly, whereas ALS increases dramatically in the first few weeks after birth. IGFBP-3 mRNA is concentrated in portal venous and sinusoidal endothelium, but is not detected in hepatocytes, whereas ALS mRNA is diffusely expressed by hepatocytes, but is not detected in nonparenchymal cells. Both transcripts are localized in the renal cortex; however, IGFBP-3 mRNA is concentrated in interstitial cells, whereas ALS is expressed in proximal tubule epithelium. Hypophysectomy results in a 90% reduction in hepatic ALS and an approximately 50% decrease in IGFBP-3 mRNA level. ALS, but not IGFBP-3, transcripts were also reduced in the kidney. GH receptor mRNA is coexpressed with ALS in liver and kidney, suggesting that the effects of GH on ALS gene expression may be direct. In summary, the fact that IGFBP-3 gene expression is far more widespread than that of ALS in both spatial and temporal parameters suggests that IGFBP-3 has a role apart from contribution to the ternary complex. We have also shown that IGFBP-3 and ALS are synthesized by distinct hepatic cell types in an anatomical organization that may serve to ensure efficient formation of the ternary complex in the blood passing through the sinusoids. Finally, the present data suggest that regulation of ALS synthesis may be the primary site of GH regulation of ternary complex formation.

This article has been cited by other articles:

				L. Liao, X. Chen, S. Wang, A. F. Parlow, and J. Xu Steroid Receptor Coactivator 3 Maintains Circulating Insulin-Like Growth Factor I (IGF-I) by Controlling IGF-Binding Protein 3 Expression Mol. Cell. Biol., April 1, 2008; 28(7): 2460 - 2469. [Abstract] [Full Text] [PDF]

				P. F. Collett-Solberg, M. Misra, and on behalf of the Drug and Therapeutics Committee o The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 10 - 18. [Abstract] [Full Text] [PDF]

				D. Engblom, J.-W. Kornfeld, L. Schwake, F. Tronche, A. Reimann, H. Beug, L. Hennighausen, R. Moriggl, and G. Schutz Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression Genes & Dev., May 15, 2007; 21(10): 1157 - 1162. [Abstract] [Full Text] [PDF]

				K. M Morrison, M. Bidlingmaier, S. Stadler, Z. Wu, L. Skriver, and C. J Strasburger Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly Eur. J. Endocrinol., March 1, 2007; 156(3): 331 - 339. [Abstract] [Full Text] [PDF]

				L. Liao, R. K. Dearth, S. Zhou, O. L. Britton, A. V. Lee, and J. Xu Liver-Specific Overexpression of the Insulin-like Growth Factor-I Enhances Somatic Growth and Partially Prevents the Effects of Growth Hormone Deficiency Endocrinology, August 1, 2006; 147(8): 3877 - 3888. [Abstract] [Full Text] [PDF]

				J. W Kim, R. P Rhoads, N. Segoale, N. B Kristensen, D. E Bauman, and Y. R Boisclair Isolation of the cDNA encoding the acid labile subunit (ALS) of the 150 kDa IGF-binding protein complex in cattle and ALS regulation during the transition from pregnancy to lactation. J. Endocrinol., June 1, 2006; 189(3): 583 - 593. [Abstract] [Full Text] [PDF]

				H. Zhou, V. N. Ivanov, J. Gillespie, C. R. Geard, S. A. Amundson, D. J. Brenner, Z. Yu, H. B. Lieberman, and T. K. Hei Mechanism of radiation-induced bystander effect: Role of the cyclooxygenase-2 signaling pathway PNAS, October 11, 2005; 102(41): 14641 - 14646. [Abstract] [Full Text] [PDF]

				J. Gibney, G. Johannsson, K.-C. Leung, and K. K. Y. Ho Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3897 - 3903. [Abstract] [Full Text] [PDF]

				X. F. Lu, X. G. Jiang, Y. B. Lu, J. H. Bai, and Z. B. Mao Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells J. Biol. Chem., June 17, 2005; 280(24): 22606 - 22615. [Abstract] [Full Text] [PDF]

				K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]

				F. Tronche, C. Opherk, R. Moriggl, C. Kellendonk, A. Reimann, L. Schwake, H. M. Reichardt, K. Stangl, D. Gau, A. Hoeflich, et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth Genes & Dev., March 1, 2004; 18(5): 492 - 497. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				M. Cisternino, M. Draghi, S. Lauriola, D. Scarcella, S. Bernasconi, L. Cavallo, F. De Luca, A. Lomeo, and L. Tato The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor-Binding Protein Complex in Girls with Central Precocious Puberty before and during Gonadotropin-Releasing Hormone Analog Therapy J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4629 - 4633. [Abstract] [Full Text] [PDF]

				J. V. Silha and L. J. Murphy Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice Endocrinology, October 1, 2002; 143(10): 3711 - 3714. [Abstract] [Full Text] [PDF]

				J. D. Wallace, W. J. Abbott-Johnson, D. H. G. Crawford, R. Barnard, J. M. Potter, and R. C. Cuneo GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2751 - 2759. [Abstract] [Full Text] [PDF]

				J. V. Silha, Y. Gui, T. Modric, A. Suwanichkul, S. K. Durham, D. R. Powell, and L. J. Murphy Overexpression of the Acid-Labile Subunit of the IGF Ternary Complex in Transgenic Mice Endocrinology, October 1, 2001; 142(10): 4305 - 4313. [Abstract] [Full Text] [PDF]

				J-G Scharf, F Dombrowski, and G Ramadori The IGF axis and hepatocarcinogenesis Mol. Pathol., June 1, 2001; 54(3): 138 - 144. [Abstract] [Full Text]

				C. Lassarre, F. Duron, and M. Binoux Use of the Ligand Immunofunctional Assay for Human Insulin-Like Growth Factor (IGF) Binding Protein-3 (IGFBP-3) to Analyze IGFBP-3 Proteolysis and IGF-I Bioavailability in Healthy Adults, GH-Deficient and Acromegalic Patients, and Diabetics J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1942 - 1952. [Abstract] [Full Text]

				M. Arosio, S. Garrone, P. Bruzzi, G. Faglia, F. Minuto, and A. Barreca Diagnostic Value of the Acid-Labile Subunit in Acromegaly: Evaluation in Comparison with Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein-1, -2, and -3 J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1091 - 1098. [Abstract] [Full Text]

				D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text]

				P. J. D. Delhanty, C. D. Scott, S. Babu, and R. C. Baxter Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E287 - E295. [Abstract] [Full Text] [PDF]

				B. Argüelles, V. Barrios, J. Pozo, M. T. Muñoz, and J. Argente Modifications of Growth Velocity and the Insulin-Like Growth Factor System in Children with Acute Lymphoblastic Leukemia: A Longitudinal Study J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4087 - 4092. [Abstract] [Full Text]

				G. Y. W. Kam, K.-C. Leung, R. C. Baxter, and Ken. K. Y. Ho Estrogens Exert Route- and Dose-Dependent Effects on Insulin-Like Growth Factor (IGF)-Binding Protein-3 and the Acid-Labile Subunit of the IGF Ternary Complex J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1918 - 1922. [Abstract] [Full Text]

				R. P. Rhoads, P. L. Greenwood, A. W. Bell, and Y. R. Boisclair Organization and Regulation of the Gene Encoding the Sheep Acid-Labile Subunit of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein Complex Endocrinology, April 1, 2000; 141(4): 1425 - 1433. [Abstract] [Full Text] [PDF]

				E. M. Zimmermann, L. Li, E. C. Hoyt, J. B. Pucilowska, S. Lichtman, and P. K. Lund Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G447 - G457. [Abstract] [Full Text] [PDF]

				A. Suwanichkul, Y. R. Boisclair, R. C. Olney, S. K. Durham, and D. R. Powell Conservation of a Growth Hormone-Responsive Promoter Element in the Human and Mouse Acid-Labile Subunit Genes Endocrinology, February 1, 2000; 141(2): 833 - 838. [Abstract] [Full Text] [PDF]

				D. LeRoith Insulin-like Growth Factors in Pediatric Health and Disease J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4355 - 4361. [Full Text]

				J. D. Wallace, R. C. Cuneo, R. Baxter, H. Orskov, N. Keay, C. Pentecost, R. Dall, T. Rosen, J. O. Jorgensen, A. Cittadini, et al. Responses of the Growth Hormone (GH) and Insulin-Like Growth Factor Axis to Exercise, GH Administration, and GH Withdrawal in Trained Adult Males: A Potential Test for GH Abuse in Sport J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3591 - 3601. [Abstract] [Full Text] [PDF]

				A. Juul, S. Møller, E. Mosfeldt-Laursen, M. H. Rasmussen, T. Scheike, S. A. Pedersen, K. W. Kastrup, H. Yu, J. Mistry, S. Rasmussen, et al. The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor Binding Protein Complex in Serum: Hepatosplanchnic Release, Diurnal Variation, Circulating Concentrations in Healthy Subjects, and Diagnostic Use in Patients with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4408 - 4415. [Abstract] [Full Text]

				G. T. Ooi, K. R. Hurst, M. N. Poy, M. M. Rechler, and Y. R. Boisclair Binding of STAT5a and STAT5b to a Single Element Resembling a {gamma}-Interferon-Activated Sequence Mediates the Growth Hormone Induction of the Mouse Acid-Labile Subunit Promoter in Liver Cells Mol. Endocrinol., May 1, 1998; 12(5): 675 - 687. [Abstract] [Full Text]

				R. A. Hill and J. M. Pell Regulation of Insulin-Like Growth Factor I (IGF-I) Bioactivity in Vivo: Further Characterization of an IGF-I-Enhancing Antibody Endocrinology, March 1, 1998; 139(3): 1278 - 1287. [Abstract] [Full Text] [PDF]

				P. J. D. Delhanty and R. C. Baxter The Regulation of Acid-Labile Subunit Gene Expression and Secretion by Cyclic Adenosine 3',5'-Monophosphate Endocrinology, January 1, 1998; 139(1): 260 - 265. [Abstract] [Full Text] [PDF]

				M. J. Khosravi, A. Diamandi, J. Mistry, R. G. Krishna, and A. Khare Acid-Labile Subunit of Human Insulin-Like Growth Factor-Binding Protein Complex: Measurement, Molecular, and Clinical Evaluation J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3944 - 3951. [Abstract] [Full Text] [PDF]

				S. Skrtic, V. Wallenius, S. Ekberg, A. Brenzel, A. M. Gressner, and J.-O. Jansson Insulin-Like Growth Factors Stimulate Expression of Hepatocyte Growth Factor But Not Transforming Growth Factor {beta}1 in Cultured Hepatic Stellate Cells Endocrinology, November 1, 1997; 138(11): 4683 - 4689. [Abstract] [Full Text] [PDF]

				N. E. Erondu, B. Toland, M. Boes, B. Dake, D. R. Moser, and R. S. Bar Bovine Insulin-Like Growth Factor Binding Protein-3: Organization of the Chromosomal Gene and Functional Analysis of Its Promoter Endocrinology, July 1, 1997; 138(7): 2856 - 2862. [Abstract] [Full Text] [PDF]

				G. T. Ooi, F. J. Cohen, L. Y.-H. Tseng, M. M. Rechler, and Y. R. Boisclair Growth Hormone Stimulates Transcription of the Gene Encoding the Acid-Labile Subunit (ALS) of the Circulating Insulin-Like Growth Factor-Binding Protein Complex and ALS Promoter Activity in Rat Liver Mol. Endocrinol., June 1, 1997; 11(7): 997 - 1007. [Abstract] [Full Text]

				Y. J. H. Janssen, M. Frolich, and F. Roelfsema A Low Starting Dose of Genotropin in Growth Hormone-Deficient Adults J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 129 - 135. [Abstract] [Full Text] [PDF]

				M. Thoren, A. Hilding, R. C. Baxter, M. Degerblad, I.-L. Wivall-Helleryd, and K. Hall Serum Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit as Serum Markers of Body Composition during Growth Hormone (GH) Therapy in Adults with GH Deficiency J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 223 - 228. [Abstract] [Full Text] [PDF]

				I. Ueki, G. T. Ooi, M. L. Tremblay, K. R. Hurst, L. A. Bach, and Y. R. Boisclair Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system PNAS, June 6, 2000; 97(12): 6868 - 6873. [Abstract] [Full Text] [PDF]